Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats

Journal of Controlled Release

Volumn 104, Issue 1, 2005, Pages 91-102

  Xin, Yu Wang ^a   Ishida, Tatsuhiro ^a   Ichihara, Masako ^a   Kiwada, Hiroshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Accelerated blood clearance (ABC) phenomenon; Liposomes; Polyethylene glycol (PEG)

Indexed keywords

BLOOD; CELLS; COATINGS; PLASMAS; SURFACE TREATMENT;

ACCELERATED BLOOD CLEARANCE (ABC); BLOOD CIRCULATION; LIPOSOMES; RATS;

LIPIDS;

CHOLESTEROL; DICETYL PHOSPHATE; LIPOSOME; MACROGOL 2000; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ARTICLE; DRUG CLEARANCE; DRUG UPTAKE; MALE; MOLECULAR SIZE; NONHUMAN; PHYSICAL CHEMISTRY; PLASMA CLEARANCE; PRIORITY JOURNAL; RAT; SURFACE PROPERTY;

EID: 18144423485     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.01.008     Document Type: Article

References (43)

1. T.M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau-Young Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 1991 29 36
2. H.M. Patel Serum opsonins and liposomes: their interaction and opsonophagocytosis Crit. Rev. Ther. Drug Carr. Syst. 9 1992 39 90
3. T. Ishida, H. Harashima, and H. Kiwada Liposome clearance Biosci. Rep. 22 2002 197 224
4. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethylene glycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237
5. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann, and F.J. Martin Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U. S. A. 88 1991 11460 11464
6. Z. Symon, A. Peyser, D. Tzemach, O. Lyass, E. Sucher, E. Shezen, and A. Gabizon Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes Cancer 86 1999 72 78
7. T. Ishida, K. Masuda, T. Ichikawa, M. Ichihara, K. Irimura, and H. Kiwada Accelerated clearance of a second injection of PEGylated liposomes in mice Int. J. Pharm. 255 2003 167 174
8. T. Ishida, R. Maeda, M. Ichihara, K. Irimura, and H. Kiwada Accelerated clearance of PEGylated liposomes in rats after repeated injections J. Control. Release 88 2003 35 42
9. E.T. Dams, P. Laverman, W.J. Oyen, G. Storm, G.L. Scherphof, J.W. van Der Meer, F.H. Corstens, and O.C. Boerman Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes J. Pharmacol. Exp. Ther. 292 2000 1071 1079
10. P. Laverman, M.G. Carstens, O.C. Boerman, E.T. Dams, W.J. Oyen, N. van Rooijen, F.H. Corstens, and G. Storm Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection J. Pharmacol. Exp. Ther. 298 2001 607 612
11. T. Ishida, T. Ichikawa, M. Ichihara, Y. Sadzuka, and H. Kiwada Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice J. Control. Release 95 2004 403 412
12. J.H. Senior Fate and behavior of liposomes in vivo: a review of controlling factors Crit. Rev. Ther. Drug Carr. Syst. 3 1987 123 193
13. J. Senior, and G. Gregoriadis Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components Life Sci. 30 1982 2123 2136
14. T.M. Allen, and A. Chonn Large unilamellar liposomes with low uptake into the reticuloendothelial system FEBS Lett. 223 1987 42 46
15. A.L. Klibanov, K. Maruyama, A.M. Beckerleg, V.P. Torchilin, and L. Huang Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target Biochim. Biophys. Acta 1062 1991 142 148
16. D.V. Devine, K. Wong, K. Serrano, A. Chonn, and P.R. Cullis Liposome-complement interactions in rat serum: implications for liposome survival studies Biochim. Biophys. Acta 1191 1994 43 51
17. P.R. Cullis, A. Chonn, and S.C. Semple Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo Adv. Drug Deliv. Rev. 32 1998 3 17
18. S.C. Semple, A. Chonn, and P.R. Cullis Influence of cholesterol on the association of plasma proteins with liposomes Biochemistry 35 1996 2521 2525
19. A. Chonn, S.C. Semple, and P.R. Cullis Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles J. Biol. Chem. 270 1995 25845 25849
20. A. Chonn, S.C. Semple, and P.R. Cullis Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes J. Biol. Chem. 267 1992 18759 18765
21. T. Ishida, H. Harashima, and H. Kiwada Interactions of liposomes with cells in vitro and in vivo: opsonins and receptors Curr. Drug Metab. 2 2001 397 409
22. T. Ishida, H. Kojima, H. Harashima, and H. Kiwada Biodistribution of liposomes and C3 fragments associated with liposomes: evaluation of their relationship Int. J. Pharm. 205 2000 183 193
23. J.A. Kamps, H.W. Morselt, and G.L. Scherphof Uptake of liposomes containing phosphatidylserine by liver cells in vivo and by sinusoidal liver cells in primary culture: in vivo-in vitro differences Biochem. Biophys. Res. Commun. 256 1999 57 62
24. T. Daemen, M. Velinova, J. Regts, M. de Jager, R. Kalicharan, J. Donga, J.J. van der Want, and G.L. Scherphof Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in the rat Hepatology 26 1997 416 423
25. F.H. Roerdink, J. Dijkstra, H.H. Spanjer, and G.L. Scherphof Interaction of liposomes with hepatocytes and Kupffer cells in vivo and in vitro Biochem. Soc. Trans. 12 1984 335 336
26. J. Dijkstra, W.J. van Galen, C.E. Hulstaert, D. Kalicharan, F.H. Roerdink, and G.L. Scherphof Interaction of liposomes with Kupffer cells in vitro Exp. Cell Res. 150 1984 161 176
27. G.R. Bartlett Phosphorus assay in column chromatography J. Biol. Chem. 234 1959 466 468
28. H. Harashima, C. Yamane, Y. Kume, and H. Kiwada Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency J. Pharmacokinet. Biopharm. 21 1993 299 308
29. V.P. Torchilin Drug targeting Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S81 S91
30. R.L. Juliano, and D. Stamp The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs Biochem. Biophys. Res. Commun. 63 1975 651 658
31. A. Gabizon, and D. Papahadjopoulos The role of surface charge and hydrophilic groups on liposome clearance in vivo Biochim. Biophys. Acta 1103 1992 94 100
32. J.A. Kamps, and G.L. Scherphof Receptor versus non-receptor mediated clearance of liposomes Adv. Drug Deliv. Rev. 32 1998 81 97
33. D. Liu, F. Liu, and Y.K. Song Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin Biochim. Biophys. Acta 1235 1995 140 146
34. G. Koch, B.D. Lok, A. van Oudenaren, and R. Benner The capacity and mechanism of bone marrow antibody formation by thymus-independent antigens J. Immunol. 128 1982 1497 1501
35. G. Koch, B.D. Lok, and R. Benner Antibody formation in mouse bone marrow during secondary type responses to various thymus-independent antigens Immunobiology 163 1982 484 496
36. J.F. Bohnsack, and E.J. Brown The role of the spleen in resistance to infection Annu. Rev. Med. 37 1986 49 59
37. T. Ishida, M. Ichihara, M. Harada, S. Kashima, X. Wang, and H. Kiwada IgM secreted in response to the first injection of PEGylated liposomes involves in induction of the ABC phenomenon 31st Annual Meeting and Exposition of the Controlled Release Society 2004
38. T. Ishida, M. Harada, M. Ichihara, T. Ichikawa, X. Wang, and H. Kiwada Factors affecting the accelerated blood clearance of PEGylated liposomes upon repeated injection in rats Molecular biopharmaceutics, a new era in drug adsorption transport and delivery 2003
39. P. Opanasopit, M. Nishikawa, and M. Hashida Factors affecting drug and gene delivery: effects of interaction with blood components Crit. Rev. Ther. Drug Carr. Syst. 19 2002 191 233
40. T.L. Cheng, P.Y. Wu, M.F. Wu, J.W. Chern, and S.R. Roffler Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM Bioconjug. Chem. 10 1999 520 528
41. U. Halm, G. Etzrodt, I. Schiefke, F. Schmidt, H. Witzigmann, J. Mossner, and F. Berr A phase II study of PEGylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma Ann. Oncol. 11 2000 113 114
42. A. Huber, O. Lyass, D. Pode, and A. Gabizon Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer Anticancer Drugs 11 2000 123 127
43. T. Daemen, G. Hofstede, M.T. Ten Kate, I.A. Bakker-Woudenberg, and G.L. Scherphof Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages Int. J. Cancer 61 1995 716 721